Cyclerion Therapeutics, Inc. Gains 41.3%
Tue, Jan 06, 2026 at 07:25 PM
Cyclerion Therapeutics, Inc. (CYCN:NASDAQ) shot up at $1.95, a gain of 41.3%. On Tue, Jan 06, 2026, CYCN:NASDAQ hit a New 2-Week High of $1.95. The stock appeared on our News Catalysts scanner on Mon, Jan 05, 2026 at 06:05 PM in the 'AGREEMENT' category. From Tue, Dec 23, 2025, the stock recorded 50.00% Up Days and 44.44% Green Days
The stock spiked on Wed, Sep 24, 2025 at $3.76 with a volume of 14M+.
About Cyclerion Therapeutics, Inc. (CYCN:NASDAQ)
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop and commercialize breakthrough treatments for serious and orphan diseases.Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators.
Top 10 Gainers:
- Alumis Inc. (ALMS:NASDAQ), 95.31%
- Sky Quarry Inc. (SKYQ:NASDAQ), 88.84%
- Autozi Internet Technology (Global) Ltd. (AZI:NASDAQ), 70.83%
- Envirotech Vehicles, Inc. (EVTV:NASDAQ), 49.01%
- Murano Global Investments Plc (MRNO:NASDAQ), 41.47%
- Cyclerion Therapeutics, Inc. (CYCN:NASDAQ), 41.3%
- Aeva Technologies, Inc. (AEVA:NASDAQ), 34.38%
- Aeva Technologies, Inc. (AEVA:NYSE), 34.38%
- Acrivon Therapeutics, Inc. (ACRV:NASDAQ), 31.44%
- Terrestrial Energy Inc Com (IMSR:NASDAQ), 30.33%